Mounjaro (Tirzepatide) Weight Management Gallery
$$MultiPurposeText$$
See examples of our Mounjaro (Tirzepatide) Weight Management work and results.
What Our Clients Say
$$MultiPurposeText$$
Read testimonials from our satisfied customers
I highly recommend this place! I recently had a tattoo removal here, and it exceeded my ex...more
I had such an amazing experience at this med spa today! From the moment I walked in, I fel...more
Saw Bernadine for the first tome last month. Knowledgable, friendly, and the beat at what ...more
I went in for three sessions of tattoo removal with Bernadine, my tattoo was extremely dar...more
Love going to Defining Beauty ... been a client for years .. wouldn't go anywhere else. B...more
Amazing place! Loved my sessions! Bernardine is great!
Frequently Asked Questions
Get answers to common questions about Mounjaro (Tirzepatide) Weight Management.
Mounjaro (tirzepatide) activates GLP-1 and GIP receptors to enhance insulin secretion, lower blood glucose, and reduce appetite. This hormonal modulation slows gastric emptying and decreases hunger signals, supporting decreased calorie intake and progressive weight loss under medical supervision.
Candidates typically have a BMI consistent with medical guidelines or obesity-related health concerns. Our clinicians review your medical history, medications, and contraindications to determine suitability and ensure safe, personalized treatment tailored to your goals.
Most side effects are gastrointestinal and mild to moderate, including nausea, vomiting, diarrhea, constipation, and decreased appetite. Symptoms often improve with time or dose adjustments. Your provider will monitor and manage any persistent or concerning effects.
Many patients notice appetite reduction and some weight change within a few weeks; clinically meaningful weight loss typically appears over months with continued dosing. Results vary by individual, dose, adherence, and lifestyle changes and are tracked regularly.
Potential interactions exist, especially with insulin or sulfonylureas which can increase hypoglycemia risk. Certain drugs affecting gastric emptying or absorption may be influenced. Disclose all prescriptions, OTC meds, and supplements so we can adjust dosing and ensure safety.
Regular follow-up visits assess weight, side effects, vitals, and metabolic labs. Providers adjust dose, review dietary and activity plans, and screen for adverse reactions. Frequency varies but often begins biweekly then moves to monthly as clinically indicated.